Roxanne Austin

(Ms. Roxanne Austin)

Currently holds positions in Abbott Laboratories, Teledyne Technologies Inc, Abbvie Inc and Target Corp

Positions

Position Company Period
Independent Director Abbott Laboratories Dec. 8, 2000 -
Independent Director Teledyne Technologies Inc Oct. 10, 2006 -
Independent Director Abbvie Inc Jan. 2, 2013 -
Independent Director Target Corp Aug. 12, 2014 -
Independent Director Telefonaktiebolaget LM Ericsson March 3, 2008 - April 13, 2016
Independent Interim Non-Executive Chairman of the Board Target Corp May 5, 2014 - Aug. 12, 2014
Independent Director Target Corp Jan. 1, 2002 - May 5, 2014
Roxanne Austin's trades of CrowdStrike Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-13 2025-06-12
S Sale
5,000 -21.5%
480.00
USD 2,400,000 		5,000 -21.5% 480.00 USD 2,400,000
2025-06-13 2025-06-12
S Sale
5,000 -21.5%
485.00
USD 2,425,000 		5,000 -21.5% 485.00 USD 2,425,000
2025-06-11 2025-06-11
S Sale
10,000 -35.3%
475.00
USD 4,750,000 		10,000 -35.3% 475.00 USD 4,750,000
2025-06-10 2025-06-09
S Sale
7,188 -28.2%
470.20
USD 3,379,798 		7,188 -28.2% 470.20 USD 3,379,798
2025-05-12 2025-05-09
PS Planned sale
6,303 -3.6%
14.75
USD 92,969 		6,303 -3.6% 14.75 USD 92,969
2025-04-11 2025-04-09
PS Planned sale
6,303 -3.5%
12.11
USD 76,329 		6,303 -3.5% 12.11 USD 76,329
2025-04-10 2025-04-09
S Sale
5,000 -21.5%
380.00
USD 1,900,000 		5,000 -21.5% 380.00 USD 1,900,000
2025-03-12 2025-03-10
PS Planned sale
6,298 -3.4%
15.28
USD 96,233 		6,298 -3.4% 15.28 USD 96,233
2025-02-18 2025-02-13
PS Planned sale
6,303 -3.3%
17.56
USD 110,681 		6,303 -3.3% 17.56 USD 110,681
2025-01-13 2025-01-10
PS Planned sale
6,303 -3.1%
15.69
USD 98,894 		6,303 -3.1% 15.69 USD 98,894
2024-12-18 2024-12-16
S Sale
5,000 -21.5%
387.01
USD 1,935,050 		5,000 -21.5% 387.01 USD 1,935,050
2024-12-11 2024-12-09
PS Planned sale
6,303 -3.1%
17.28
USD 108,916 		6,303 -3.1% 17.28 USD 108,916
2024-11-12 2024-11-11
PS Planned sale
6,303 -3.0%
16.44
USD 103,621 		6,303 -3.0% 16.44 USD 103,621
2024-10-11 2024-10-09
PS Planned sale
6,303 -2.9%
11.10
USD 69,963 		6,303 -2.9% 11.10 USD 69,963
2024-09-11 2024-09-09
PS Planned sale
6,298 -2.8%
11.48
USD 72,301 		6,298 -2.8% 11.48 USD 72,301
2024-08-13 2024-08-09
PS Planned sale
6,303 -2.7%
11.22
USD 70,720 		6,303 -2.7% 11.22 USD 70,720
2024-07-11 2024-07-09
PS Planned sale
6,303 -2.7%
12.49
USD 78,724 		6,303 -2.7% 12.49 USD 78,724
2024-07-02 2024-07-02
PS Planned sale
6,101 -2.5%
12.92
USD 78,825 		6,101 -2.5% 12.92 USD 78,825
2024-07-02 2024-06-28
S Sale
5,000 -21.5%
391.01
USD 1,955,050 		5,000 -21.5% 391.01 USD 1,955,050
2024-06-28 2024-06-27
S Sale
10,000 -35.3%
390.01
USD 3,900,100 		10,000 -35.3% 390.01 USD 3,900,100
2024-06-11 2024-06-10
PS Planned sale
25,207 -10.1%
12.70
USD 320,129 		25,207 -10.1% 12.70 USD 320,129
2024-02-09 2024-02-09
PS Planned sale
6,303 -6.7%
21.54
USD 135,767 		6,303 -6.7% 21.54 USD 135,767
2024-01-10 2024-01-09
PS Planned sale
6,303 -6.2%
22.58
USD 142,322 		6,303 -6.2% 22.58 USD 142,322
2023-12-12 2023-12-11
PS Planned sale
6,303 -5.9%
20.10
USD 126,690 		6,303 -5.9% 20.10 USD 126,690
2023-11-13 2023-11-09
PS Planned sale
6,303 -5.6%
18.05
USD 113,769 		6,303 -5.6% 18.05 USD 113,769
2023-10-13 2023-10-11
S Sale
5,000 -22.1%
185.25
USD 926,250 		5,000 -22.1% 185.25 USD 926,250
2023-10-10 2023-10-10
S Sale
5,000 -18.1%
185.01
USD 925,050 		5,000 -18.1% 185.01 USD 925,050
2023-10-11 2023-10-09
PS Planned sale
6,303 -5.3%
19.20
USD 121,018 		6,303 -5.3% 19.20 USD 121,018
2023-10-10 2023-10-06
S Sale
5,000 -15.3%
172.25
USD 861,250 		5,000 -15.3% 172.25 USD 861,250
2023-10-10 2023-10-06
S Sale
5,000 -13.3%
172.01
USD 860,050 		5,000 -13.3% 172.01 USD 860,050
2023-09-12 2023-09-11
PS Planned sale
6,303 -5.0%
22.07
USD 139,107 		6,303 -5.0% 22.07 USD 139,107
2023-08-10 2023-08-09
PS Planned sale
6,298 -4.8%
21.47
USD 135,218 		6,298 -4.8% 21.47 USD 135,218
2023-07-18 2023-07-17
S Sale
20,000 -34.7%
154.32
USD 3,086,406 		20,000 -34.7% 154.32 USD 3,086,406
2023-07-18 2023-07-14
S Sale
1,968 -3.3%
152.24
USD 299,608 		1,968 -3.3% 152.24 USD 299,608
2023-07-18 2023-07-14
S Sale
3,032 -4.8%
149.32
USD 452,735 		3,032 -4.8% 149.32 USD 452,735
2023-07-13 2023-07-13
S Sale
15,000 -19.3%
152.77
USD 2,291,550 		15,000 -19.3% 152.77 USD 2,291,550
2023-07-13 2023-07-13
S Sale
30,000 -27.9%
151.63
USD 4,549,002 		30,000 -27.9% 151.63 USD 4,549,002
2023-07-13 2023-07-12
S Sale
5,000 -4.4%
153.39
USD 766,930 		5,000 -4.4% 153.39 USD 766,930
2023-07-13 2023-07-11
S Sale
5,000 -4.2%
151.50
USD 757,517 		5,000 -4.2% 151.50 USD 757,517
2023-07-12 2023-07-10
PS Planned sale
6,303 -4.6%
16.19
USD 102,046 		6,303 -4.6% 16.19 USD 102,046
2023-07-03 2023-07-03
PS Planned sale
7,962 -5.5%
17.35
USD 138,141 		7,962 -5.5% 17.35 USD 138,141
2023-06-09 2023-06-09
PS Planned sale
25,212 -15.9%
15.76
USD 397,341 		25,212 -15.9% 15.76 USD 397,341
2023-02-21 2023-02-17
US Abbvie Inc (ABBV)
S Sale
10,000 -19.7%
150.50
USD 1,505,000 		10,000 -19.7% 150.50 USD 1,505,000
2023-02-14 2023-01-05
B Purchase
15,500 +15.4%
99.00
USD 1,534,500 		15,500 +15.4% 99.00 USD 1,534,500
2023-01-06 2023-01-05
B Purchase
15,000 +17.6%
97.59
USD 1,463,900 		15,000 +17.6% 97.59 USD 1,463,900
// ... existing code ...